Literature DB >> 29719428

Factors associated with imaging in patients with early breast cancer after initial treatment.

K Enright1, T Desai2, R Sutradhar2,3, A Gonzalez3, M Powis4, N Taback2, C M Booth5, M E Trudeau6, M K Krzyzanowska3,4.   

Abstract

Background: Overuse of surveillance imaging in patients after curative treatment for early breast cancer (ebc) was recently identified as one of the Choosing Wisely Canada initiatives to improve the quality of cancer care. We undertook a population-level examination of imaging practices in Ontario as they existed before the launch of that initiative.
Methods: Patients diagnosed with ebc between 2006 and 2010 in Ontario were identified from the Ontario Cancer Registry. Records were linked deterministically to provincial health care databases to obtain comprehensive follow-up. We identified all advanced imaging exams [aies: computed tomography (ct), bone scan, positron-emission tomography] and basic imaging exams (bies: ultrasonography, chest radiography) occurring within the first 2 years after curative treatment. Poisson regression was used to assess associations between patient or provider characteristics and the rate of aies.
Results: Of 30,006 women with ebc, 58.6% received at least 1 bie, and 30.6% received at least 1 aie in year 1 after treatment. In year 2, 52.7% received at least 1 bie, and 25.7% received at least 1 aie. The most common aies were chest cts and bone scans. The rate of aies increased with older age, higher disease stage, comorbidity, chemotherapy exposure, and prior staging investigations (p < 0.001). Imaging was ordered mainly by medical oncologists (38%), followed by primary care physicians (23%), surgeons (13%), and emergency room physicians (7%). Conclusions: Despite recommendations against its use, imaging is common in ebc survivors. Understanding the factors associated with aie use helps to identify areas for further research and is required to lower imaging rates and to improve survivorship care.

Entities:  

Keywords:  Early breast cancer; curative treatment; imaging overuse

Mesh:

Year:  2018        PMID: 29719428      PMCID: PMC5927783          DOI: 10.3747/co.25.3838

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  24 in total

1.  Primary care physician use across the breast cancer care continuum: CanIMPACT study using Canadian administrative data.

Authors:  Li Jiang; Aisha Lofters; Rahim Moineddin; Kathleen Decker; Patti Groome; Cynthia Kendell; Monika Krzyzanowska; Dongdong Li; Mary L McBride; Nicole Mittmann; Geoff Porter; Donna Turner; Robin Urquhart; Marcy Winget; Yang Zhang; Eva Grunfeld
Journal:  Can Fam Physician       Date:  2016-10       Impact factor: 3.275

Review 2.  Survivors of breast cancer: patient perspectives on survivorship care planning.

Authors:  Sally L Smith; Savitri Singh-Carlson; Lindsay Downie; Nancy Payeur; Elaine S Wai
Journal:  J Cancer Surviv       Date:  2011-06-04       Impact factor: 4.442

3.  Addressing overutilization in medical imaging.

Authors:  William R Hendee; Gary J Becker; James P Borgstede; Jennifer Bosma; William J Casarella; Beth A Erickson; C Douglas Maynard; James H Thrall; Paul E Wallner
Journal:  Radiology       Date:  2010-08-24       Impact factor: 11.105

4.  Are primary care providers prepared to care for survivors of breast cancer in the safety net?

Authors:  Aaron J Dawes; Marian Hemmelgarn; David K Nguyen; Greg D Sacks; Sheilah M Clayton; Jacqueline R Cope; Patricia A Ganz; Melinda Maggard-Gibbons
Journal:  Cancer       Date:  2014-12-23       Impact factor: 6.860

5.  Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines.

Authors:  Thejaswi K Poonacha; Ronald S Go
Journal:  J Clin Oncol       Date:  2010-12-13       Impact factor: 44.544

6.  Health system costs for stage-specific breast cancer: a population-based approach.

Authors:  N Mittmann; J M Porter; J Rangrej; S J Seung; N Liu; R Saskin; M C Cheung; N B Leighl; J S Hoch; M Trudeau; W K Evans; K N Dainty; C DeAngelis; C C Earle
Journal:  Curr Oncol       Date:  2014-12       Impact factor: 3.677

7.  Surveillance of patients with breast cancer after curative-intent primary treatment: current practice patterns.

Authors:  Julie A Margenthaler; Emad Allam; Ling Chen; Katherine S Virgo; Udayan Mayur Kulkarni; Anand P Patel; Frank E Johnson
Journal:  J Oncol Pract       Date:  2011-12-13       Impact factor: 3.840

Review 8.  The GIVIO trial on the impact of follow-up care on survival and quality of life in breast cancer patients. Interdisciplinary Group for Cancer Care Evaluation.

Authors:  A Liberati
Journal:  Ann Oncol       Date:  1995       Impact factor: 32.976

Review 9.  Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.

Authors:  James L Khatcheressian; Patricia Hurley; Elissa Bantug; Laura J Esserman; Eva Grunfeld; Francine Halberg; Alexander Hantel; N Lynn Henry; Hyman B Muss; Thomas J Smith; Victor G Vogel; Antonio C Wolff; Mark R Somerfield; Nancy E Davidson
Journal:  J Clin Oncol       Date:  2012-11-05       Impact factor: 44.544

10.  Patterns of diagnostic imaging and associated radiation exposure among long-term survivors of young adult cancer: a population-based cohort study.

Authors:  Corinne Daly; David R Urbach; Thérèse A Stukel; Paul C Nathan; Wayne Deitel; Lawrence F Paszat; Andrew S Wilton; Nancy N Baxter
Journal:  BMC Cancer       Date:  2015-09-03       Impact factor: 4.430

View more
  5 in total

Review 1.  A scoping review characterizing "Choosing Wisely®" recommendations for breast cancer management.

Authors:  Hely Shah; Julian Surujballi; Arif Ali Awan; Brian Hutton; Angel Arnaout; Risa Shorr; Lisa Vandermeer; Mashari Jemaan Alzahrani; Mark Clemons
Journal:  Breast Cancer Res Treat       Date:  2020-11-06       Impact factor: 4.872

2.  Screening for new primary cancers in patients with metastatic breast cancer: a provincial analysis of the Choosing Wisely Canada recommendations.

Authors:  M Tesch; K Laing
Journal:  Curr Oncol       Date:  2019-06-01       Impact factor: 3.677

3.  Use of Routine Health Datasets to Assess the Appropriateness of Diagnostic Tests in the Follow-Up of Breast Cancer Patients: A Population-Based Study on 3930 Patients.

Authors:  Massimo Gion; Giulia Cardinali; Stefano Guzzinati; Paolo Morandi; Chiara Trevisiol; Aline S C Fabricio; Massimo Rugge; Manuel Zorzi
Journal:  Risk Manag Healthc Policy       Date:  2022-05-19

4.  Adherence to post-surgery follow-up assessment and its association with sociodemographic and disease characteristics in patients with breast cancer in Central China.

Authors:  Ran Feng; Jingfeng Jing; Xiaojun Zhang; Ming Li; Jinnan Gao
Journal:  BMC Cancer       Date:  2020-11-12       Impact factor: 4.430

5.  De-implementing low-value care in cancer care delivery: a systematic review.

Authors:  Amir Alishahi Tabriz; Kea Turner; Alecia Clary; Young-Rock Hong; Oliver T Nguyen; Grace Wei; Rebecca B Carlson; Sarah A Birken
Journal:  Implement Sci       Date:  2022-03-12       Impact factor: 7.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.